Melissa Sato

Melissa Sato brings over 15 years of biopharma experience specializing in analytical sciences, including mass spectrometry and chromatography for mAbs, BiTEs, fusion proteins, and oligonucleotides. She brings over 10 years of experience in Multi-Attribute Method expanding across development to GMP from her roles at Amgen and Thermo Fisher Fisher Scientific. At Amgen, she was an integral part of implementing MAM in GMP and co-authored a patent on sequential enzymatic digestion for MS analysis. Now at Agilent, Melissa leads the MAM Software product and oversees BioConfirm and ExDViewer, driving innovation in biopharma mass spectrometry applications.